Trial intelligence / Profile preview

Anticoagulation After Endoscopic Therapy in Cirrhotic PVT

NCT02398357Phase 4Unknown

Sponsor
Zhongshan Hospital, Fudan University
Start
Mar 2015
Primary completion
Aug 2017
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nadroparin, warfarin in portal vein thrombosis (PVT), sponsored by Zhongshan Hospital, Fudan University. Status: unknown.

02

Drugs

nadroparinwarfarin
03

Conditions

portal vein thrombosis (PVT)

Beyond the preview

Go deeper on NCT02398357.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02398357.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call